References:
1. García-Kutzbach A, Chacón-Súchite J, García-Ferrer H, Iraheta I.
Reactive arthritis: update 2018. Clin Rheumatol. 2018 Apr;37(4):869–74.
2. Schmitt SK. Reactive Arthritis. Infect Dis Clin North Am. 2017
Jun;31(2):265–77.
3. Jubber A, Moorthy A. Reactive arthritis: a clinical review. J R Coll
Physicians Edinb. 2021 Sep;51(3):288–97.
4. Meier K, Schloegl A, Poddubnyy D, Ghoreschi K. Skin manifestations in
spondyloarthritis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20975915.
5. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A.
A new approach to defining disease status in ankylosing spondylitis: the
Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994
Dec;21(12):2286–91.
6. Wilson G, Folzenlogen DD. Spondyloarthropathies: New Directions in
Etiopathogenesis, Diagnosis and Treatment. Mo Med. 2012;109(1):69–74.
7. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and
medical management. Rheum Dis Clin North Am. 2009 Feb;35(1):21–44.
8. Cheeti A, Chakraborty RK, Ramphul K. Reactive Arthritis
[Internet]. StatPearls [Internet]. StatPearls Publishing; 2022
[cited 2022 Mar 3]. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK499831/
9. Slouma M, Chammakhi M, Dhahri R, Metoui L, Boussetta N, Ajili F, et
al. Unusual evolution of reactive arthritis induced by BCG therapy.
Therapie. 2019 Dec;74(6):685–8.
10. Liew IY, Mak TM, Cui L, Vasoo S, Lim XR. A Case of Reactive
Arthritis Secondary to Coronavirus Disease 2019 Infection. J Clin
Rheumatol Pract Rep Rheum Musculoskelet Dis. 2020 Sep;26(6):233.
11. Selmi C, Gershwin ME. Diagnosis and classification of reactive
arthritis. Autoimmun Rev. 2014 May;13(4–5):546–9.
12. Carlin EM, Ziza JM, Keat A, Janier M. 2014 European Guideline on the
management of sexually acquired reactive arthritis. Int J STD AIDS. 2014
Nov;25(13):901–12.
13. Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad and more. J
Am Acad Dermatol. 2008 Jul;59(1):113–21.
14. Aitken-Saavedra J, Maturana-Ramirez A, Fernández Moraga J, Doro Dias
V, Galdino-Santos L, Pineda Flores D. Reactive arthritis: images.
Dermatol Online J. 2021 Jul 15;27(7).
15. Thomsen NH, Hørslev-Petersen K, Simonsen EE. Complete heart block in
Reiter’s syndrome. Dan Med Bull. 1985 Oct;32(5):272–3.
16. Ruppert GB, Lindsay J, Barth WF. Cardiac conduction abnormalities in
Reiter’s syndrome. Am J Med. 1982 Sep;73(3):335–40.
17. Rossen RM, Goodman DJ, Harrison DC. A-V conduction disturbances in
Reiter’s syndrome. Am J Med. 1975 Feb;58(2):280–4.
18. Brown LE, Forfia P, Flynn JA. Aortic Insufficiency in a Patient with
Reactive Arthritis: Case Report and Review of the Literature. HSS J.
2011 Jul;7(2):187–9.
19. Hamdulay SS, Glynne SJ, Keat A. When is arthritis reactive? Postgrad
Med J. 2006 Jul 1;82(969):446–53.
20. Willkens RF, Arnett FC, Bitter T, Calin A, Fisher L, Ford DK, et al.
Reiter’s syndrome. Evaluation of preliminary criteria for definite
disease. Arthritis Rheum. 1981 Jun;24(6):844–9.
21. Pennisi M, Perdue J, Roulston T, Nicholas J, Schmidt E, Rolfs J. An
overview of reactive arthritis. JAAPA Off J Am Acad Physician Assist.
2019 Jul;32(7):25–8.
22. Zeidler H, Hudson AP. Reactive Arthritis Update: Spotlight on New
and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep.
2021 Jul 1;23(7):53.
23. Sieper J, Braun J, Kingsley GH. Report on the Fourth International
Workshop on Reactive Arthritis. Arthritis Rheum. 2000 Apr;43(4):720–34.
24. Kvien TK, Glennås A, Melby K. Prediction of diagnosis in acute and
subacute oligoarthritis of unknown origin. Br J Rheumatol. 1996
Apr;35(4):359–63.
25. Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou
CT, et al. The Assessment of SpondyloArthritis International Society
classification criteria for peripheral spondyloarthritis and for
spondyloarthritis in general. Ann Rheum Dis. 2011 Jan;70(1):25–31.
26. Barber CE, Kim J, Inman RD, Esdaile JM, James MT. Antibiotics for
Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis. J
Rheumatol. 2013 Jun 1;40(6):916–28.
27. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Mottonen T, Hakola M,
Korpela M, et al. Effect of a three month course of ciprofloxacin on the
late prognosis of reactive arthritis. Ann Rheum Dis. 2003
Sep;62(9):880–4.
28. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR, et
al. Comparison of sulfasalazine and placebo in the treatment of reactive
arthritis (Reiter’s syndrome). A Department of Veterans Affairs
Cooperative Study. Arthritis Rheum. 1996 Dec;39(12):2021–7.
29. Palazzi C, Olivieri I, D’Amico E, Pennese E, Petricca A. Management
of reactive arthritis. Expert Opin Pharmacother. 2004 Jan;5(1):61–70.
30. Kingsley G, Sieper J. Third International Workshop on Reactive
Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.
Ann Rheum Dis. 1996 Aug;55(8):564–84.
31. BANICIOIU-COVEI S, VREJU FA, CIUREA P. Predictive Factors for the
Evolution of Reactive Arthritis to Ankylosing Spondylitis. Curr Health
Sci J. 2015;41(2):104–8.
32. Leirisalo-Repo M. Prognosis, course of disease, and treatment of the
spondyloarthropathies. Rheum Dis Clin North Am. 1998 Nov;24(4):737–51,
viii.
33. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011
Jun;25(3):347–57.
34. Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis
or post-infectious arthritis? Best Pract Res Clin Rheumatol. 2006
Jun;20(3):419–33.
Figures legend:
Figure 1: Dactylitis of the right third finger
(arrow)
Figure 2: Plantar papulosquamous
plaques